STRO
Price
$2.01
Change
+$0.16 (+8.65%)
Updated
Jan 17 closing price
Capitalization
165.74M
67 days until earnings call
TCRX
Price
$2.40
Change
-$0.06 (-2.44%)
Updated
Jan 17 closing price
Capitalization
135.61M
46 days until earnings call
Ad is loading...

STRO vs TCRX

Header iconSTRO vs TCRX Comparison
Open Charts STRO vs TCRXBanner chart's image
Sutro Biopharma
Price$2.01
Change+$0.16 (+8.65%)
Volume$1.31M
Capitalization165.74M
TScan Therapeutics
Price$2.40
Change-$0.06 (-2.44%)
Volume$238.54K
Capitalization135.61M
STRO vs TCRX Comparison Chart
Loading...
STRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
STRO vs. TCRX commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STRO is a Hold and TCRX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (STRO: $2.01 vs. TCRX: $2.40)
Brand notoriety: STRO and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: STRO: 112% vs. TCRX: 50%
Market capitalization -- STRO: $165.74M vs. TCRX: $135.61M
STRO [@Biotechnology] is valued at $165.74M. TCRX’s [@Biotechnology] market capitalization is $135.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

STRO’s FA Score shows that 1 FA rating(s) are green whileTCRX’s FA Score has 1 green FA rating(s).

  • STRO’s FA Score: 1 green, 4 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, both STRO and TCRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

STRO’s TA Score shows that 4 TA indicator(s) are bullish while TCRX’s TA Score has 4 bullish TA indicator(s).

  • STRO’s TA Score: 4 bullish, 3 bearish.
  • TCRX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both STRO and TCRX are a good buy in the short-term.

Price Growth

STRO (@Biotechnology) experienced а +8.65% price change this week, while TCRX (@Biotechnology) price change was -13.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

STRO is expected to report earnings on May 19, 2025.

TCRX is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STRO($166M) has a higher market cap than TCRX($136M). STRO YTD gains are higher at: 9.239 vs. TCRX (-21.053). STRO has higher annual earnings (EBITDA): -69.95M vs. TCRX (-102.91M). STRO has more cash in the bank: 388M vs. TCRX (271M). STRO has less debt than TCRX: STRO (24.9M) vs TCRX (90.4M). STRO has higher revenues than TCRX: STRO (161M) vs TCRX (9.36M).
STROTCRXSTRO / TCRX
Capitalization166M136M122%
EBITDA-69.95M-102.91M68%
Gain YTD9.239-21.053-44%
P/E RatioN/AN/A-
Revenue161M9.36M1,720%
Total Cash388M271M143%
Total Debt24.9M90.4M28%
FUNDAMENTALS RATINGS
STRO: Fundamental Ratings
STRO
OUTLOOK RATING
1..100
63
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
STROTCRX
RSI
ODDS (%)
Bullish Trend 11 days ago
78%
Bullish Trend 11 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 11 days ago
88%
Bullish Trend 11 days ago
89%
Momentum
ODDS (%)
Bullish Trend 11 days ago
86%
Bearish Trend 11 days ago
90%
MACD
ODDS (%)
Bullish Trend 11 days ago
80%
Bullish Trend 11 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
81%
Bearish Trend 11 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 11 days ago
89%
Advances
ODDS (%)
Bullish Trend 13 days ago
79%
Bullish Trend 17 days ago
82%
Declines
ODDS (%)
Bearish Trend 11 days ago
87%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 11 days ago
89%
Bearish Trend 11 days ago
90%
View a ticker or compare two or three
Ad is loading...
STRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
UPAAX14.770.24
+1.65%
Upright Assets Allocation Plus
HNDDX72.280.59
+0.82%
Horizon Equity Premium Income Investor
WRGCX6.630.04
+0.61%
Macquarie Small Cap Growth C
DVZRX73.530.25
+0.34%
Macquarie Small Cap Value R6
GDSTX26.31N/A
N/A
Goldman Sachs Small Cap Eq Insghts Inv

STRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, STRO has been loosely correlated with NUVB. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if STRO jumps, then NUVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STRO
1D Price
Change %
STRO100%
+8.65%
NUVB - STRO
52%
Loosely correlated
-1.18%
TRDA - STRO
47%
Loosely correlated
+1.20%
STOK - STRO
46%
Loosely correlated
-1.06%
ALGS - STRO
44%
Loosely correlated
+8.32%
XENE - STRO
42%
Loosely correlated
-2.78%
More

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with CRVO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then CRVO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
-2.44%
CRVO - TCRX
41%
Loosely correlated
N/A
PRME - TCRX
40%
Loosely correlated
+0.70%
FATE - TCRX
39%
Loosely correlated
+1.60%
ALLO - TCRX
39%
Loosely correlated
-1.09%
STRO - TCRX
38%
Loosely correlated
+8.65%
More